CEOWORLD magazine - Archive in Christina DiArcangelo

Christina DiArcangelo

Christina DiArcangelo

An entrepreneur and CEO with more than two decades of experience in the biotechnology, pharmaceutical, nutraceutical, and medical device industries, Christina DiArcangelo’s dedication to revolutionizing patient care is unprecedented. Through her roles as CEO, Spectral Analytics Precision Tele-Monitoring, Affinity Bio Partners, Board President and CEO of Affinity Patient Advocacy, Christina has been involved with revolutionary projects and global clinical studies that positively impact patients.

Christina was a participant and winner in Season 2 of the “Four Days to Save the World” TV Series that will be released on Earth Day 2022. As a clinical research pioneer, contracts negotiator, and business owner, she has utilized the tools at her disposal to champion patient care and provide best-in-class patient advocacy services. For Christina, patient care comes first.

Christina DiArcangelo is an opinion columnist for the CEOWORLD magazine. You can follow her on LinkedIn. For more information, visit the author’s website.
CEO Insights

Having an all-women executive board of directors can bring several benefits.

In this article, I am going to outline six potential advantages of developing an all-women executive board of directors. I have created and developed an all women led executive board for one of my organizations and want to share some the advantages that I see. The first advantage is gender...
1 2
Page 1 of 2